Ballooned Intercostal Drain Trial

Status Recruiting

Clinical Trial Summary

This study is designed to assess whether a new type of chest drain reduces the number of drains that fall out of or are accidentally removed from the chest cavity (usually requiring another drain to be inserted), without causing any increase in discomfort or other side-effects.

Clinical Trial Description

Chest drains are an essential part of the treatment for patients with fluid or air around the lung, which usually causes breathlessness. Draining the fluid or air relieves symptoms and allows investigations to be carried out that can identify a cause for why the fluid or air is there. Chest drains are difficult to secure in place, and sometimes fall out despite the best possible care. This study tests a modified drain that has a small balloon near the end which, when inflated inside the chest cavity, should make it much harder for the drain to fall out of the chest. This was tested in a small pilot study, with encouraging results. The current study is comparing a group of patients treated with the new ballooned drain against a group treated with the standard drain, with patients equally but randomly allocated to each group. The chest drain has been through rigorous laboratory testing and has been CE marked for human use.

All patients requiring intercostal drainage for clinical reasons will be offered entry into the study, unless, in the view of the treating physician, blunt dissection is required. No other screening assessments will be required, other than the ability to sign the informed consent form.Patients who have provided signed informed consent will then proceed to the study protocol. Patients will be randomised to undergo either standard ICT insertion (usual clinical care) or insertion of the study drain using standard clinical policies and procedures at each participating centre.

Once a patient has been identified for the trial and has signed the informed consent form, baseline details will be entered into a dedicated web-based programme accessible at all sites, and patients will be allocated 1:1 to either usual care or to the study drain.

All subsequent care will be as per best clinical care for all patients in both arms of the study. The only additional assessments over and above usual care will be the collection of pain scores. Pain will be rated by the patients on a visual analogue scale (VAS) on up to 4 occasions - insertion, 24 and 72 hours post insertion, and at drain removal. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03000504
Study type	Interventional
Source	Royal Brompton & Harefield NHS Foundation Trust
Contact	Samuel V Kemp, MBBS, MD
Phone	+442073518021
Email	s.kemp@rbht.nhs.uk
Status	Recruiting
Phase	N/A
Start date	March 7, 2018
Completion date	July 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04159831` - A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions	Phase 2
Recruiting	`NCT02891642` - Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Completed	`NCT02232841` - Electrical Impedance Imaging of Patients on Mechanical Ventilation	N/A
Completed	`NCT02045641` - Pleural and Pericardial Effusion Following Open Heart Surgery	N/A
Completed	`NCT01948076` - Evaluation of a Pocket-Sized Ultrasound Device As an Aid to the Physical Examination	N/A
Completed	`NCT01416519` - Physiotherapy Technique Decreases Respiratory Complications After Cardiac Operation	N/A
Completed	`NCT01560078` - Efficacy Study of Thrice Weekly Directly Observed Treatment Short-Course Regimen in Tubercular Pleural Effusion	N/A
Completed	`NCT04891705` - Point of Care Ultrasound Lung Artificial Intelligence (AI) Validation Data Collection Study
Recruiting	`NCT05759117` - Prospective Evaluation of Patients With Pleural Effusion
Recruiting	`NCT05910112` - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed	`NCT03896672` - Clinical Implementation of the Use of Positive Pressure in Chest Drainage	N/A
Active, not recruiting	`NCT06075836` - AI Assisted Detection of Chest X-Rays
Recruiting	`NCT03728491` - Education and Training Competences in Thoracic Ultrasound	N/A
Not yet recruiting	`NCT03260088` - Evaluation Of Pleural Effusion At Assiut University Hospital	N/A
Completed	`NCT03535883` - The Safety of Thoracentesis, Tunneled Pleural Catheter, and Chest Tubes in Patients Taking Novel Oral Anti-Coagulants
Completed	`NCT03296280` - Evaluation of Implementation of a National Point-of-Care Ultrasound Training Program
Completed	`NCT03661801` - Novel Pleural Fluid, Biopsy and Serum Biomarkers for the Investigation of Pleural Effusions
Completed	`NCT01778270` - Not Invasive Monitoring of Pleural Drainage	N/A
Terminated	`NCT00402896` - Malignant Pleural Effusion With ZD6474	Phase 2
Recruiting	`NCT00103766` - Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.